Propel Bio Management »

Sutro Biopharma shares owned by Propel Bio Management

Quarter-by-quarter ownership of Sutro Biopharma (STRO) shares owned by Propel Bio Management from 13F filings

Historical chart of Propel Bio Management investment in Sutro Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Sutro Biopharma held by Propel Bio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sutro Biopharma by Propel Bio Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $837k 195k 4.29

More positions owned by Propel Bio Management

Plains Gp Holdings Lp-cl Comm (PAGP)
Applied Therapeutics Comm (APLT)
Tscan Therapeutics Comm (TCRX)
Madrigal Pharmaceuticals Comm (MDGL)
Crinetics Pharmaceuticals In Comm (CRNX)
Fulcrum Therapeutics Comm (FULC)
Fidelity Inv Mmtrsy 1 680 Comm
Phathom Pharmaceuticals Comm (PHAT)
Day One Biopharmaceuticals I Comm (DAWN)
Ardelyx Comm (ARDX)
Athira Pharma Comm (ATHA)
Telesat Corp Comm (TSAT)
Simplify Enhanced Income Comm (HIGH)
Akero Therapeutics Comm (AKRO)
Vanguard Short-term Bond Comm (BSV)

View all positions for Propel Bio Management

Top funds holding Sutro Biopharma

BVF
Vanguard Group
Franklin Resources
Kynam Capital Management
Baillie Gifford & Co
Samsara BioCapital
Millennium Management
Dimensional Fund Advisors
Goldman Sachs Group
Candriam Luxembourg S.C.A.
Vontobel Holding
PanAgora Asset Management
Pentwater Capital Management
Aquilo Capital Management
Jacobs Levy Equity Management

View all funds holding Sutro Biopharma